Press releases
Biological Psychiatry Study Shows Speech-Latency Vocal Biomarker Can Strengthen Drug–Placebo Separation in Schizophrenia Trials
February 26, 2026Clario leads the way in responsible artificial intelligence with ISO 42001 certification, audited by Schellman
February 18, 2026Thermo Fisher Scientific to Acquire Clario, Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
October 29, 2025Clario and the University of Oxford’s NeuroMetrology Lab Advance Parkinson’s Disease Research with the Opal® Wearable Sensor System
October 6, 2025Clario expands oncology trial support through collaboration with Radialogica to enhance radiation therapy quality control
September 23, 2025Clario Announces Completion of Acquisition of WCG’s eCOA Business
May 6, 2025Media coverage
MEDIA COVERAGE
Lauren Misztal interviewed about responsible use of AI
October 15, 2024MEDIA COVERAGE
Jay Ferro featured on “Spotlight on Procurement” podcast
August 28, 2024MEDIA COVERAGE
Todd Rudo, M.D. addresses DEI data gaps on BioSpace’s Denatured podcast
July 29, 2024MEDIA COVERAGE
Clario Partners with Emsere, Extends Ophthalmic Medical Imaging Capabilities
May 29, 2024MEDIA COVERAGE
Clario Solutions Enhancing Patient Care with AI in Clinical Trials
May 10, 2024MEDIA COVERAGE
Clario recognized as a top Biotechnology Company in 2024
March 8, 2024Briefings
Media contact
Journalists with inquiries about Clario, please email our Media Team at [email protected].